These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 36767947)
1. Soluble ST2 as a New Oxidative Stress and Inflammation Marker in Metabolic Syndrome. Roy I; Jover E; Matilla L; Alvarez V; Fernández-Celis A; Beunza M; Escribano E; Gainza A; Sádaba R; López-Andrés N Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767947 [TBL] [Abstract][Full Text] [Related]
3. Soluble ST2 Levels and Left Ventricular Structure and Function in Patients With Metabolic Syndrome. Celic V; Majstorovic A; Pencic-Popovic B; Sljivic A; Lopez-Andres N; Roy I; Escribano E; Beunza M; Melero A; Floridi F; Magrini L; Marino R; Salerno G; Cardelli P; Di Somma S Ann Lab Med; 2016 Nov; 36(6):542-9. PubMed ID: 27578507 [TBL] [Abstract][Full Text] [Related]
4. Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction. Fousteris E; Melidonis A; Panoutsopoulos G; Tzirogiannis K; Foussas S; Theodosis-Georgilas A; Tzerefos S; Matsagos S; Boutati E; Economopoulos T; Dimitriadis G; Raptis S Cardiovasc Diabetol; 2011 Nov; 10():101. PubMed ID: 22104207 [TBL] [Abstract][Full Text] [Related]
5. Relationship between Soluble ST2 and Left Ventricular Geometry in Maintenance Hemodialysis Patients. Zhang Z; Xie Y; Shen B; Nie Y; Cao X; Xiang F; Zou J Blood Purif; 2021; 50(1):84-92. PubMed ID: 33291107 [TBL] [Abstract][Full Text] [Related]
6. Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy. Obradovic DM; Büttner P; Rommel KP; Blazek S; Loncar G; von Haehling S; von Roeder M; Lücke C; Gutberlet M; Thiele H; Lurz P; Besler C Cells; 2022 Jan; 11(3):. PubMed ID: 35159224 [TBL] [Abstract][Full Text] [Related]
7. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction. AbouEzzeddine OF; McKie PM; Dunlay SM; Stevens SR; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28214792 [TBL] [Abstract][Full Text] [Related]
9. Soluble ST2 and CXCL-10 may serve as biomarkers of subclinical diastolic dysfunction in SLE and correlate with disease activity and damage. Chorin E; Hochstadt A; Arad U; Ghantous E; Gertel S; Levartovsky D; Litinsky I; Elaluof O; Polachek A; Kaufman I; Aloush V; Borok S; Wigler I; Wollman J; Caspi D; Laufer-Perl M; Letourneau-Shesaf S; Berliner S; Elkayam O; Topilsky Y; Paran D Lupus; 2020 Oct; 29(11):1430-1437. PubMed ID: 32772796 [TBL] [Abstract][Full Text] [Related]
10. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium. Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671 [TBL] [Abstract][Full Text] [Related]
11. Soluble ST2: a new and promising activity marker in ulcerative colitis. Díaz-Jiménez D; Núñez LE; Beltrán CJ; Candia E; Suazo C; Alvarez-Lobos M; González MJ; Hermoso MA; Quera R World J Gastroenterol; 2011 May; 17(17):2181-90. PubMed ID: 21633527 [TBL] [Abstract][Full Text] [Related]
12. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Shah RV; Chen-Tournoux AA; Picard MH; van Kimmenade RR; Januzzi JL Circ Heart Fail; 2009 Jul; 2(4):311-9. PubMed ID: 19808354 [TBL] [Abstract][Full Text] [Related]
13. Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients. Zhu K; Xia C; Chen J; Yu C; Gao T; Yan J; Shao N; Zhu P; Sun B; Ren X; Zhang Y Mediators Inflamm; 2021; 2021():5576596. PubMed ID: 34194284 [TBL] [Abstract][Full Text] [Related]
15. Soluble ST2: A complex and diverse role in several diseases. Homsak E; Gruson D Clin Chim Acta; 2020 Aug; 507():75-87. PubMed ID: 32305537 [TBL] [Abstract][Full Text] [Related]
16. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. Weir RA; Miller AM; Murphy GE; Clements S; Steedman T; Connell JM; McInnes IB; Dargie HJ; McMurray JJ J Am Coll Cardiol; 2010 Jan; 55(3):243-50. PubMed ID: 20117403 [TBL] [Abstract][Full Text] [Related]
17. Soluble ST2 and brain natriuretic peptide predict different mode of death in patients with heart failure and preserved ejection fraction. Sugano A; Seo Y; Ishizu T; Sai S; Yamamoto M; Hamada-Harimura Y; Machino-Ohtsuka T; Obara K; Nishi I; Aonuma K; Nogami A J Cardiol; 2019 Apr; 73(4):326-332. PubMed ID: 30580891 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor-related protein ST2 and mitral valve repair outcome in patients with chronic degenerative mitral regurgitation. Galeone A; Lessana A; Mascolo E; Di Serio F; Marraudino N; Laborde F; Paparella D Thorac Cardiovasc Surg; 2014 Feb; 62(1):47-51. PubMed ID: 24065602 [TBL] [Abstract][Full Text] [Related]
19. Ability of soluble ST2 to predict left ventricular remodeling in patients with acute coronary syndrome. Park S; Kim IC; Kim H; Cho YK; Lee CH; Hur SH Heart Vessels; 2022 Feb; 37(2):173-183. PubMed ID: 34341876 [TBL] [Abstract][Full Text] [Related]
20. Serum Soluble ST2 as a Novel Inflammatory Marker in Acute Ischemic Stroke. Chen W; Lin A; Yu Y; Zhang L; Yang G; Hu H; Luo Y Clin Lab; 2018 Sep; 64(9):1349-1356. PubMed ID: 30274001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]